首页> 外国专利> Prediction of EGFR inhibitor effect by BRAF mutation detection

Prediction of EGFR inhibitor effect by BRAF mutation detection

机译:BRAF突变检测预测EGFR抑制剂效应

摘要

PROBLEM TO BE SOLVED To develop a novel marker for predicting treatment effect of EGFR inhibitor of BRAF mutation in order to more accurately judge adaptability to EGFR inhibitor.A method for detecting a mutation in human BRAF that predicts a therapeutic effect of an EGFR inhibitor of the present invention comprises using a patient's biological sample to detect mutations in human BRAF protein G469, L485 , Q 524, L 525, D 594 and V 600, wherein the tumor in which mutation of said gene has been detected is detected in said tumor, It is not suitable for treatment with BRAF-mediated signal transduction system inhibitors.
机译:开发一种新的标记以预测预测BRAF突变EGFR抑制剂的治疗效果,以更准确地判断EGFR抑制剂的适应性。一种检测人BRAF中突变的方法,其预测EGFR抑制剂的治疗效果本发明包括使用患者的生物样品检测人BRAF蛋白G469,L485,Q 524,L 525,D 594和V 600中的突变,其中在所述肿瘤中检测到所述基因突变的肿瘤不适合用Braf介导的信号转导系统抑制剂治疗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号